Dravet Syndrome Market Outlook:
Dravet Syndrome Market size was over USD 590.48 million in 2025 and is anticipated to cross USD 1.42 billion by 2035, witnessing more than 9.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of dravet syndrome is assessed at USD 639.37 million.
The reason behind the growth is impelled by the increasing child population. Moreover, Dravet syndrome is an uncommon kind of epilepsy that starts in infancy or early childhood and can lead to frequent, protracted seizures, which may require treatment including medication or other therapies to decrease the severity and amount of seizures.According to estimates, the number of children worldwide is projected to be over 1 billion in 2100.
The growing research & development are believed to fuel the dravet syndrome treatment market. For instance, in 2020 STK-001 an anti-sense oligonucleotide was administered, to the first patient with Dravet syndrome as part of a clinical trial to increase the expression of SCN1A in the brain.
